4.7 Article

The efficacy and selectivity of tumor cell killing by Akt inhibitors are substantially increased by chloroquine

Journal

BIOORGANIC & MEDICINAL CHEMISTRY
Volume 16, Issue 17, Pages 7888-7893

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2008.07.076

Keywords

chloroquine; PI3K-Akt inhibitors; breast cancer; cell killing; sensitization; chemotherapeutics

Funding

  1. Canadian Breast Cancer Foundation
  2. The Ontario Institute of Cancer Research/Cancer Care Ontario
  3. The Northern Cancer Research Foundation

Ask authors/readers for more resources

This study was to evaluate the enhancement value of chloroquine (CQ) in cancer cell killing when used in combination with Akt inhibitors. The results showed that the combination of CQ and Akt inhibitors is much more effective than either one alone. Importantly, the CQ-mediated chemosensitization of cell killing effects by Akt inhibitors is cancer specific. In particular, when combined with 10 mu M CQ, 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one (an Akt1 and 2 inhibitor; compound 8) killed cancer cells 10-120 times more effectively than normal cells. Thus, CQ is a very effective and cancer-specific chemosensitizer when used in combination with Akt inhibitors. (C) 2008 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available